SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 193.05+1.7%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Harold Conn who wrote (13422)1/17/1998 7:21:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
Harold, Thanks for the heads up. That was the third article that I was looking for. It's a bit later than I expected and I had stopped looking. Thus my "source" was 3 for 3 on the articles. I had expected articles in the online version of Business Week, the Financial Times, and the NY Times. I guess the editors have quite a bit of leway on determining what is "news".

I suspect that the Rezulin news put a damper on things and forced a slightly different spin to the articles. The news hit hardest in Great Britain, and it was reflected in the tone of the Financial Times article. I thought that LGND was well presented in the NY Times article. I think its pretty clear who the major player will be among the smaller Biotechs. I'm still amazed at the press that ERGO gets and time will tell if it's deserved. I'm still waiting to see who their partner is and from what I understand, H&Q is still big on them, even though H&Q intially talked about the deal being completed 6 months ago.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext